rethinkPeptides Search
Menu
Study breakdown

Intravenous CGRP Triggers Light Sensitivity and Head Pain in Rat Migraine Model

evidence
The takeaway

Intravenous CGRP injection in rats produced light-aversive behavior and facial sensitivity, validating a translational model for migraine photophobia research.

Both sexes affected

IV CGRP model produces light-aversion and facial pain in male and female rats

What the researchers found

Intravenous CGRP induced light-aversion and cephalic allodynia in male and female rats, providing a translational model for migraine photophobia.

Why it matters

Better animal models for migraine photophobia are needed to develop and test new treatments. This IV model is more clinically relevant than intracranial injection approaches.

How the study worked

Preclinical study using IV CGRP injection in male and female rats with behavioral assessment of light-aversion and facial sensitivity at controlled light intensities.

What this study cannot tell us

Animal model — rat behavior may not perfectly mirror human migraine photophobia; IV CGRP pharmacokinetics differ between species.

How to read the evidence

Preclinical animal model study — establishes methodology for future research but does not directly demonstrate clinical benefit.

When this study was published

Published 2026 in The Journal of Headache and Pain.

The bigger picture

Anti-CGRP therapies (like erenumab, fremanezumab, galcanezumab) are already used for migraine prevention. Understanding CGRP's role in photophobia through better models may refine these treatments.

Questions still open

  • Does this model respond appropriately to existing anti-CGRP migraine treatments?
  • Are the light-aversion thresholds comparable to human photophobia levels?

Common questions

What is CGRP's role in migraine?
CGRP is a peptide released during migraines that causes blood vessel dilation and pain signaling. Anti-CGRP drugs are now used to prevent migraines.
Why is photophobia important in migraine research?
Light sensitivity is one of the most disabling migraine symptoms. Understanding its mechanisms through animal models helps develop better targeted treatments.

Read the original research

Light-aversion and cephalic allodynia in an intravenous CGRP model of migraine-like behaviour in male and female rats.

The journal of headache and pain, 27(1), 45

Citation

Andersen, Veronika K; Hansen, Bjarke S; Fungbrant, Emelie; Hestehave, Sara; Haanes, Kristian A; Nordahl, Karin M L. (2026). Light-aversion and cephalic allodynia in an intravenous CGRP model of migraine-like behaviour in male and female rats.. The journal of headache and pain, 27(1), 45. https://doi.org/10.1186/s10194-026-02278-2